Welcome to our dedicated page for Churchill Cap X news (Ticker: CCCX), a resource for investors and traders seeking the latest updates and insights on Churchill Cap X stock.
News related to Churchill Capital Corp X (NASDAQ: CCCX) focuses heavily on its role as a blank check company pursuing a business combination with ColdQuanta, Inc., known in press releases as Infleqtion. Because Churchill Capital Corp X is a special purpose acquisition company, its news flow is closely tied to transaction milestones, regulatory filings, and joint announcements with its proposed merger partner.
Recent releases describe the filing of a joint registration statement on Form S-4 with the U.S. Securities and Exchange Commission in connection with the proposed business combination. These communications explain that the Form S-4 includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders and outline the process for soliciting proxies and holding a shareholder vote on the transaction.
Many CCCX news items are joint announcements with Infleqtion. They reference Infleqtion’s plans to go public through a merger with Churchill Capital Corp X and describe the expected structure of the combined company, including that it is anticipated to operate as “Infleqtion, Inc.” and to be listed under the ticker “INFQ” upon closing, subject to approvals and customary conditions. These releases also highlight Infleqtion’s activities in neutral-atom quantum technology, such as quantum computing and precision sensing, as context for the proposed transaction.
Investors following CCCX news can use this page to monitor updates on the Merger Agreement, SEC review of the registration statement, proxy materials, and other disclosures connected to the business combination process. Because forward-looking statements and risk factors are a recurring theme in these communications, readers are frequently directed to Churchill Capital Corp X’s SEC filings for more detailed information.
Bookmark this news feed to track ongoing announcements about Churchill Capital Corp X, its proposed merger with Infleqtion, and key regulatory and shareholder milestones that may affect CCCX and any future combined company.
Infleqtion (NYSE:INFQ) completed its business combination with Churchill Capital Corp X (CCCX) and will begin trading on the NYSE on February 17, 2026 under INFQ and INFQ WS. Churchill X has delisted from Nasdaq and its units have been separated and are no longer listed.
Infleqtion positions itself as the first publicly listed neutral-atom quantum technology company, offering quantum computers, precision sensors, clocks, RF receivers, inertial sensors, and proprietary software, with partnerships and customers including NVIDIA, the U.S. Department of War, NASA, and the U.K. government.
Churchill Capital Corp X (NASDAQ: CCCX) shareholders approved the business combination with Infleqtion, clearing a transaction expected to close on February 13, 2026. Over 90% of votes supported the deal, which will deliver more than $550 million of gross proceeds to Infleqtion, including a >$125 million PIPE.
Post-close the combined company will be renamed Infleqtion, Inc., delist from Nasdaq and list on the NYSE as INFQ (shares) and INFQ WS (warrants) beginning February 17, 2026, subject to closing and NYSE requirements.
Infleqtion (NASDAQ: CCCX) announced that Founder & Chief Science Officer Dr. Dana Anderson was elected to the National Academy of Engineering for contributions to optical quantum engineering of ultracold atoms. The company also noted plans to go public via a merger with Churchill Capital Corp X.
Dr. Anderson will be honored at the NAE induction ceremony in October; the recognition underscores Infleqtion’s scientific credentials as it advances atom-based quantum sensing and computing.
Infleqtion (NASDAQ: CCCX) is a collaborator on NASA’s Quantum Gravity Gradiometer Pathfinder (QGGPf), a mission to fly the first standalone quantum gravity sensor in low Earth orbit. The program has more than $20 million in contracted mission funding to date and targets a one-year flight demonstration expected to launch in 2030.
Infleqtion will design and integrate the sensor's quantum core (vacuum, laser, control subsystems) and build on prior work with JPL and the Cold Atom Lab to advance space-based quantum sensing for Earth science, navigation, and security.
Infleqtion (NASDAQ: CCCX) executed a $6.2 million ARPA-E contract to launch the ENCODE program, developing quantum-enhanced methods for electricity grid optimization in partnership with Argonne, the National Laboratory of the Rockies, EPRI, and ComEd.
The company highlights a 1,600-qubit neutral-atom array and 12 logical qubits with error detection as technical foundations for scalable, energy-efficient grid solutions.
Infleqtion demonstrated a GPS-free quantum timing solution in partnership with Quantum Corridor, achieving up to 40X improvement over GPS and picosecond-level synchronization across 21.8 kilometers of live urban fiber between Chicago and Hammond, IN. The test used Infleqtion’s rack-mounted Tiqker atomic clock on Quantum Corridor’s purpose-built, quantum-safe fiber.
The collaboration supports commercial timing services for financial trading, data centers, telecom, and national security and follows Infleqtion’s planned merger to go public via Churchill Capital Corp X (NASDAQ: CCCX).
Infleqtion (NASDAQ: CCCX) was chosen to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge to test quantum-enabled biomarker discovery on real oncology data. The team, with UChicago and MIT collaborators, will move experiments from simulation to real quantum processors and apply a hybrid quantum–classical workflow to forecast treatment response in head-and-neck cancer.
The announcement accompanies a new arXiv paper and comes as Infleqtion prepares to go public via a merger with Churchill Capital Corp X.
Churchill Capital Corp X (CCCX) announced it will transfer its Class A ordinary shares and public warrants from Nasdaq to the New York Stock Exchange and change post‑combination trading symbols to INFQ and INFQ WS.
The company will re-domicile by continuation from the Cayman Islands to Delaware and convert units, shares and warrants on a one‑for‑one basis. Trading on Nasdaq is expected to end at market close on February 13, 2026 and NYSE trading to begin at market open on February 17, 2026. An Extraordinary General Meeting is set for February 12, 2026 for shareholder approval.
Infleqtion (NASDAQ: CCCX) and University of Wisconsin–Madison researchers demonstrated nondestructive qubit measurement with user-facing fidelities up to 99.93%, using a forbidden quadrupole transition in cesium while simultaneously cooling atoms. The team outlined a scalable path to 99.95% fidelity in ~60 microseconds, enabling faster computation cycles and improved error correction for neutral‑atom quantum systems.
Infleqtion (NASDAQ: CCCX) appointed Dave Kresse as Vice President of Commercial Solutions, effective January 29, 2026. Kresse brings 30+ years building and scaling technology businesses and joins from Amazon Web Services to lead commercial efforts across AI, energy, materials, drug discovery, and advanced data centers.
Infleqtion noted its product portfolio includes quantum computers, optical clocks, RF receivers, and inertial sensors, and cited deployments with U.S. government agencies, NASA, and collaborations with NVIDIA.